211 related articles for article (PubMed ID: 25556151)
1. Antitumor effects of hyaluronan inhibition in desmoid tumors.
Briggs A; Rosenberg L; Buie JD; Rizvi H; Bertagnolli MM; Cho NL
Carcinogenesis; 2015 Feb; 36(2):272-9. PubMed ID: 25556151
[TBL] [Abstract][Full Text] [Related]
2. Fragmented hyaluronan is an autocrine chemokinetic motility factor supported by the HAS2-HYAL2/CD44 system on the plasma membrane.
Saito T; Kawana H; Azuma K; Toyoda A; Fujita H; Kitagawa M; Harigaya K
Int J Oncol; 2011 Nov; 39(5):1311-20. PubMed ID: 21743962
[TBL] [Abstract][Full Text] [Related]
3. Expression patterns of hyaluronan, hyaluronan synthases and hyaluronidases indicate a role for hyaluronan in the progression of endometrial cancer.
Paiva P; Van Damme MP; Tellbach M; Jones RL; Jobling T; Salamonsen LA
Gynecol Oncol; 2005 Aug; 98(2):193-202. PubMed ID: 15936804
[TBL] [Abstract][Full Text] [Related]
4. Altered expression of hyaluronan, HAS1-2, and HYAL1-2 in oral lichen planus.
Siponen M; Kullaa A; Nieminen P; Salo T; Pasonen-Seppänen S
J Oral Pathol Med; 2015 Jul; 44(6):401-9. PubMed ID: 25421996
[TBL] [Abstract][Full Text] [Related]
5. Extensive CD44-dependent hyaluronan coats on human bone marrow-derived mesenchymal stem cells produced by hyaluronan synthases HAS1, HAS2 and HAS3.
Qu C; Rilla K; Tammi R; Tammi M; Kröger H; Lammi MJ
Int J Biochem Cell Biol; 2014 Mar; 48():45-54. PubMed ID: 24406795
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of hyaluronan synthesis in breast cancer cells by 4-methylumbelliferone suppresses tumorigenicity in vitro and metastatic lesions of bone in vivo.
Urakawa H; Nishida Y; Wasa J; Arai E; Zhuo L; Kimata K; Kozawa E; Futamura N; Ishiguro N
Int J Cancer; 2012 Jan; 130(2):454-66. PubMed ID: 21387290
[TBL] [Abstract][Full Text] [Related]
7. 4-methylumbelliferone leads to growth arrest and apoptosis in canine mammary tumor cells.
Saito T; Tamura D; Nakamura T; Makita Y; Ariyama H; Komiyama K; Yoshihara T; Asano R
Oncol Rep; 2013 Jan; 29(1):335-42. PubMed ID: 23124556
[TBL] [Abstract][Full Text] [Related]
8. Antitumor effects of hyaluronic acid inhibitor 4-methylumbelliferone in an orthotopic hepatocellular carcinoma model in mice.
Piccioni F; Malvicini M; Garcia MG; Rodriguez A; Atorrasagasti C; Kippes N; Piedra Buena IT; Rizzo MM; Bayo J; Aquino J; Viola M; Passi A; Alaniz L; Mazzolini G
Glycobiology; 2012 Mar; 22(3):400-10. PubMed ID: 22038477
[TBL] [Abstract][Full Text] [Related]
9. Tumor-suppressive functions of 4-MU on breast cancer cells of different ER status: Regulation of hyaluronan/HAS2/CD44 and specific matrix effectors.
Karalis TT; Heldin P; Vynios DH; Neill T; Buraschi S; Iozzo RV; Karamanos NK; Skandalis SS
Matrix Biol; 2019 May; 78-79():118-138. PubMed ID: 29673760
[TBL] [Abstract][Full Text] [Related]
10. Antitumor effects of 4-methylumbelliferone, a hyaluronan synthesis inhibitor, on malignant peripheral nerve sheath tumor.
Ikuta K; Ota T; Zhuo L; Urakawa H; Kozawa E; Hamada S; Kimata K; Ishiguro N; Nishida Y
Int J Cancer; 2017 Jan; 140(2):469-479. PubMed ID: 27706810
[TBL] [Abstract][Full Text] [Related]
11. The over-expression of HAS2, Hyal-2 and CD44 is implicated in the invasiveness of breast cancer.
Udabage L; Brownlee GR; Nilsson SK; Brown TJ
Exp Cell Res; 2005 Oct; 310(1):205-17. PubMed ID: 16125700
[TBL] [Abstract][Full Text] [Related]
12. The hyaluronic acid inhibitor 4-methylumbelliferone is an NSMase2 activator-role of Ceramide in MU anti-tumor activity.
Qin J; Kilkus J; Dawson G
Biochim Biophys Acta; 2016 Feb; 1861(2):78-90. PubMed ID: 26548718
[TBL] [Abstract][Full Text] [Related]
13. Critical role of hyaluronidase-2 during preimplantation embryo development.
Marei WF; Salavati M; Fouladi-Nashta AA
Mol Hum Reprod; 2013 Sep; 19(9):590-9. PubMed ID: 23625939
[TBL] [Abstract][Full Text] [Related]
14. HAS3-related hyaluronan enhances biological activities necessary for metastasis of osteosarcoma cells.
Tofuku K; Yokouchi M; Murayama T; Minami S; Komiya S
Int J Oncol; 2006 Jul; 29(1):175-83. PubMed ID: 16773198
[TBL] [Abstract][Full Text] [Related]
15. Human leukemic cell lines synthesize hyaluronan to avoid senescence and resist chemotherapy.
Lompardía SL; Papademetrio DL; Mascaró M; Álvarez EM; Hajos SE
Glycobiology; 2013 Dec; 23(12):1463-76. PubMed ID: 24013961
[TBL] [Abstract][Full Text] [Related]
16. Expression of HYAL2 mRNA, hyaluronan and hyaluronidase in B-cell non-Hodgkin lymphoma: relationship with tumor aggressiveness.
Bertrand P; Courel MN; Maingonnat C; Jardin F; Tilly H; Bastard C
Int J Cancer; 2005 Jan; 113(2):207-12. PubMed ID: 15386412
[TBL] [Abstract][Full Text] [Related]
17. 4-Methylumbelliferone Suppresses Hyaluronan Synthesis and Tumor Progression in SCID Mice Intra-abdominally Inoculated With Pancreatic Cancer Cells.
Nagase H; Kudo D; Suto A; Yoshida E; Suto S; Negishi M; Kakizaki I; Hakamada K
Pancreas; 2017 Feb; 46(2):190-197. PubMed ID: 27846148
[TBL] [Abstract][Full Text] [Related]
18. Involvement of hyaluronan and its receptor CD44 with choroidal neovascularization.
Mochimaru H; Takahashi E; Tsukamoto N; Miyazaki J; Yaguchi T; Koto T; Kurihara T; Noda K; Ozawa Y; Ishimoto T; Kawakami Y; Tanihara H; Saya H; Ishida S; Tsubota K
Invest Ophthalmol Vis Sci; 2009 Sep; 50(9):4410-5. PubMed ID: 19339747
[TBL] [Abstract][Full Text] [Related]
19. Changes in epidermal hyaluronan metabolism following UVB irradiation.
Tobiishi M; Sayo T; Yoshida H; Kusaka A; Kawabata K; Sugiyama Y; Ishikawa O; Inoue S
J Dermatol Sci; 2011 Oct; 64(1):31-8. PubMed ID: 21752603
[TBL] [Abstract][Full Text] [Related]
20. Hyaluronidase 1 and hyaluronidase 2 are required for renal hyaluronan turnover.
Colombaro V; Jadot I; Declèves AE; Voisin V; Giordano L; Habsch I; Flamion B; Caron N
Acta Histochem; 2015 Jan; 117(1):83-91. PubMed ID: 25468725
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
